Anika Therapeutics Reports First-Quarter 2013 Financial Results

Published: May 02, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today reported financial results for the quarter ended March 31, 2013.

“Anika began 2013 with a solid first quarter,” said Charles H. Sherwood, Ph.D., president and chief executive officer. “Our Orthobiologics franchise continues to be strong.

Help employers find you! Check out all the jobs and post your resume.

Back to news